Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,786,000 | 1,587,000 | 1,801,000 | 2,151,000 | 1,121,000 |
| Marketable Securities | 10,437,000 | 20,325,000 | 20,993,000 | 8,199,000 | 8,525,000 |
| Receivables | 7,913,000 | 10,012,000 | 9,128,000 | 9,881,000 | 6,772,000 |
| Inventories | 8,020,000 | 9,295,000 | 8,564,000 | 8,423,000 | 7,068,000 |
| Income taxes - deferred | 3,264,000 | N/A | 3,426,000 | 3,346,000 | 2,736,000 |
| Other current assets | 3,647,000 | 6,520,000 | 2,512,000 | 2,738,000 | 6,581,000 |
| TOTAL | $35,067,000 | $47,739,000 | $46,424,000 | $34,738,000 | $32,803,000 |
| Non-Current Assets | |||||
| PPE Net | 13,745,000 | 14,403,000 | 14,113,000 | 14,040,000 | 12,969,000 |
| Investments And Advances | 20,262,000 | 19,008,000 | 18,720,000 | 18,220,000 | 20,147,000 |
| Intangibles | 77,893,000 | 90,829,000 | 91,990,000 | 92,966,000 | 82,138,000 |
| Other Non-Current Assets | 7,262,000 | 7,004,000 | 6,687,000 | 6,373,000 | 19,537,000 |
| TOTAL | $119,162,000 | $131,244,000 | $131,510,000 | $131,599,000 | $134,791,000 |
| Total Assets | $154,229,000 | $178,983,000 | $177,934,000 | $166,336,000 | $167,594,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,703,000 | 13,363,000 | 13,084,000 | 16,007,000 | 16,195,000 |
| Accounts payable and accrued liabilities | 4,283,000 | 4,141,000 | 3,872,000 | 3,972,000 | 3,887,000 |
| Accrued Expenses | 3,049,000 | 2,425,000 | 2,042,000 | 2,246,000 | 2,390,000 |
| Other current liabilities | 11,561,000 | 10,683,000 | 10,168,000 | 10,515,000 | 9,334,000 |
| TOTAL | $25,920,000 | $34,154,000 | $32,723,000 | $33,890,000 | $37,304,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,133,000 | 49,785,000 | 50,529,000 | 36,281,000 | 35,955,000 |
| Deferred Revenues | 1,113,000 | N/A | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 23,629,000 | 25,000,000 | 24,702,000 | 25,550,000 | 25,228,000 |
| TOTAL | $64,836,000 | $79,335,000 | $80,648,000 | $67,108,000 | $66,844,000 |
| Total Liabilities | $90,756,000 | $113,487,000 | $113,370,000 | $100,998,000 | $104,148,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,577,630 | 5,558,396 | 5,556,880 | 5,554,834 | 5,547,639 |
| Common Shares | 470,000 | 470,000 | 470,000 | 470,000 | 468,000 |
| Retained earnings | 90,392,000 | 100,284,000 | 100,203,000 | 101,000,000 | 97,670,000 |
| Other shareholders' equity | -5,075,000 | -12,440,000 | -13,017,000 | -12,802,000 | -11,318,000 |
| TOTAL | $63,473,000 | $65,495,000 | $64,564,000 | $65,338,000 | $63,447,000 |
| Total Liabilities And Equity | $154,229,000 | $178,982,000 | $177,934,000 | $166,336,000 | $167,595,000 |